HLA-DPA1 and rheumatoid arthritis: HLA-DPA1 was identified as a common drug target for both Sjogren's syndrome and multiple sclerosis in a previous study [56], while another study more directly by weighted gene co-expression network (WGCNA) and linkage map (CMap) of illustrating HLA-DPA1 as a drug target for RA [57].